{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:08:47Z","timestamp":1778476127049,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF2OSA0066111"],"award-info":[{"award-number":["NNF2OSA0066111"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"RWTH Aachen University Medical Faculty","doi-asserted-by":"publisher","award":["520275106"],"award-info":[{"award-number":["520275106"]}],"id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["PTD 1\\u201311"],"award-info":[{"award-number":["PTD 1\\u201311"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["SFB TRR 219\\u2013322900939 - M07"],"award-info":[{"award-number":["SFB TRR 219\\u2013322900939 - M07"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011566","name":"Marga und Walter Boll-Stiftung","doi-asserted-by":"publisher","award":["M \\u2212 05"],"award-info":[{"award-number":["M \\u2212 05"]}],"id":[{"id":"10.13039\/501100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","award":["S199\/10084\/2021"],"award-info":[{"award-number":["S199\/10084\/2021"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","award":["SFB TRR 219\\u2013322900939 - M \\u2212 03"],"award-info":[{"award-number":["SFB TRR 219\\u2013322900939 - M \\u2212 03"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","award":["LE 1350\/9-1"],"award-info":[{"award-number":["LE 1350\/9-1"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","award":["M \\u2212 02"],"award-info":[{"award-number":["M \\u2212 02"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KL2004"],"award-info":[{"award-number":["01KL2004"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["JTC-2019"],"award-info":[{"award-number":["JTC-2019"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007555","name":"Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.atherosclerosis.2025.120220","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:43:43Z","timestamp":1748259823000},"page":"120220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD"],"prefix":"10.1016","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1313-152X","authenticated-orcid":false,"given":"Berkan","family":"Kurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Rau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reugels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Just","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian A.","family":"Wenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Moellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Spie\u00dfh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Milzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinan","family":"Kneizeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simina-Ramona","family":"Selejan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiel P.C.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lehrke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-2562","authenticated-orcid":false,"given":"Florian","family":"Kahles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"44","key":"10.1016\/j.atherosclerosis.2025.120220_bib1","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1093\/eurheartj\/ehad597","article-title":"Towards personalized cardiovascular care: Global registry of acute coronary events 3.0 score heralds artificial intelligence era","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur Heart J"},{"issue":"40","key":"10.1016\/j.atherosclerosis.2025.120220_bib2","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1093\/eurheartj\/ehae465","article-title":"Artificial intelligence in cardiovascular medicine: clinical applications","volume":"45","author":"L\u00fcscher","year":"2024","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.120220_bib3","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120220_bib4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","article-title":"Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score","volume":"99","author":"Dorresteijn","year":"2013","journal-title":"Heart"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.120220_bib5","first-page":"1419","article-title":"Distribution of estimated 10-Year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","year":"2016","journal-title":"Circulation (New York, N Y)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120220_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157340211799304761","article-title":"Adrenomedullin function in vascular endothelial cells: insights from genetic mouse models","volume":"7","author":"Karpinich","year":"2011","journal-title":"Curr Hypertens Rev"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2025.120220_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(93)90214-3","article-title":"Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats","volume":"241","author":"Ishiyama","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120220_bib9","first-page":"842","article-title":"Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis","volume":"127","author":"Koyama","year":"2013","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.atherosclerosis.2025.120220_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2018.00292","article-title":"Adrenomedullin and adrenomedullin-targeted therapy as treatment strategies relevant for sepsis","volume":"9","author":"Geven","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.120220_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2015.06.061","article-title":"Bench-to-bedside pharmacology of Adrenomedullin","volume":"764","author":"Kato","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120220_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.peptides.2011.05.022","article-title":"Shared and separate functions of the RAMP-Based Adrenomedullin receptors","volume":"32","author":"Kuwasako","year":"2011","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1373\/jalm.2017.023655","article-title":"Sandwich immunoassay for bioactive plasma adrenomedullin","volume":"2","author":"Weber","year":"2017","journal-title":"J. Appli. Laboratory Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib14","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/cc13731","article-title":"Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis","volume":"18","author":"Marino","year":"2014","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib15","first-page":"312","article-title":"Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis","volume":"152","author":"Caironi","year":"2017","journal-title":"Chest (Am Coll Chest Physicians)"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/SHK.0000000000001103","article-title":"Vascular effects of Adrenomedullin and the anti-adrenomedullin antibody adrecizumab in sepsis","volume":"50","author":"Geven","year":"2018","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s13054-018-2243-2","article-title":"Circulating Adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational adrenomedullin and outcome in sepsis and septic Shock-1 (AdrenOSS-1) study","volume":"22","author":"Mebazaa","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CCM.0000000000004044","article-title":"Bioactive adrenomedullin, organ support therapies, and survival in the critically ill: results from the French and european outcome registry in ICU study","volume":"48","author":"Lemasle","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s13054-020-03351-1","article-title":"Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness","volume":"24","author":"Lundberg","year":"2020","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120220_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00392-021-01909-9","article-title":"Activity of the Adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure","volume":"111","author":"Kozhuharov","year":"2022","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120220_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ejhf.1437","article-title":"Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure","volume":"21","author":"ter Maaten","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120220_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ejhf.1245","article-title":"Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure","volume":"20","author":"Kremer","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120220_bib23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ejhf.1693","article-title":"Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission","volume":"22","author":"Pandhi","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001048","article-title":"Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting","volume":"6","author":"Molvin","year":"2019","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","article-title":"Quantifying the added value of new biomarkers: how and how not","volume":"2","author":"Cook","year":"2018","journal-title":"Diagnostic Prognostic Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-11-13","article-title":"One statistical test is sufficient for assessing new predictive markers","volume":"11","author":"Vickers","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120220_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120220_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2018.4242","article-title":"Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120220_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120220_bib30","first-page":"1955","article-title":"Clinical usefulness of very high and very low levels of C-Reactive protein across the full range of framingham risk scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation (New York, N Y)"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2025.120220_bib31","first-page":"2243","article-title":"C-Reactive protein and parental history improve global cardiovascular risk prediction","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation (New York, N Y)"},{"issue":"10118","key":"10.1016\/j.atherosclerosis.2025.120220_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.120220_bib33","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"9670","key":"10.1016\/j.atherosclerosis.2025.120220_bib34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120220_bib35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-Reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Emerging Risk Factors","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2025.120220_bib36","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/eurheartj\/ehn334","article-title":"NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus","volume":"29","author":"Huelsmann","year":"2008","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120220_bib37","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/dc13-1165","article-title":"The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes","volume":"37","author":"Hillis","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120220_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE trial","volume":"50","author":"Omland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120220_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2016.08.001","article-title":"NT-proBNP is a powerful predictor for incident atrial fibrillation - validation of a multimarker approach","volume":"223","author":"Svennberg","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide\u2013based screening and collaborative care for heart failure","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120220_bib42","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00125-014-3375-9","article-title":"N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study","volume":"57","author":"Price","year":"2014","journal-title":"Diabetologia (Berl)"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2025.120220_bib43","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"37","author":"Blankenberg","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120220_bib44","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamacardio.2019.4130","article-title":"Association of circulating metabolites with risk of coronary heart disease in a European population: results from the biomarkers for cardiovascular risk assessment in Europe (BiomarCaRE) consortium","volume":"4","author":"Cavus","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120220_bib45","series-title":"BEST (biomarkers, EndpointS, and other tools) resource. BEST (biomarkers, EndpointS, and other tools) resource","year":"2016"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120220_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp Biol Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120220_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120220_bib48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/EJA.0000000000001662","article-title":"The value of bioactive Adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: a prospective cohort study","volume":"39","author":"van Lier","year":"2022","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120220_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1024\/0301-1526\/a000848","article-title":"Postoperatively increased bioactive adrenomedullin is related to adverse outcome after complex aortic surgery","volume":"49","author":"Gombert","year":"2020","journal-title":"Vasa"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120220_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63412-1","article-title":"Postoperative bioactive Adrenomedullin is associated with the onset of ARDS and adverse outcomes in patients undergoing open thoracoabdominal aortic surgery","volume":"14","author":"Doukas","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120220_bib51","first-page":"e596","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation (New York, N Y)"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.120220_bib52","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2025.120220_bib53","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2025.120220_bib54","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"issue":"Supplement_1","key":"10.1016\/j.atherosclerosis.2025.120220_bib55","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.2337\/dc25-S010","article-title":"10. Cardiovascular disease and risk management: standards of care in Diabetes\u20142025","volume":"48","author":"Elsayed","year":"2025","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120220_bib56","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120220_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","article-title":"Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors","volume":"121","author":"Joseph","year":"2017","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120220_bib58","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","article-title":"Safety and tolerability of non-neutralizing Adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial","volume":"47","author":"Laterre","year":"2021","journal-title":"Intensive Care Med"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120220_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009217","article-title":"Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model","volume":"7","author":"Kaasenbrood","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120220_bib60","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/eurjpc\/zwab093","article-title":"Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals","volume":"29","author":"McKay","year":"2022","journal-title":"Eur J Prev Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025011189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025011189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:22:36Z","timestamp":1778473356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025011189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"alternative-id":["S0021915025011189"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120220","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120220"}}